AAAAAA
Results:
1-13
|
Results: 13
Authors:
Jelic, S
Mitrovic, L
Radosavljevic, D
Elezar, E
Babovic, N
Kovcin, V
Tomasevic, Z
Kovacevic, S
Gavrilovic, D
Radulovic, S
Citation: S. Jelic et al., Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study, LUNG CANC, 34(1), 2001, pp. 1-13
Authors:
Konjevic, G
Jovic, V
Radulovic, S
Jelic, S
Dzodic, R
Spuzic, I
Citation: G. Konjevic et al., Therapeutic implications of the kinetics of immunomodulation during singleor combined treatment of melanoma patients with dacarbazine and interferon-alpha, NEOPLASMA, 48(3), 2001, pp. 175-181
Authors:
Alousy, A
Burgess, J
Elvidge, D
Hubbard, CD
Radulovic, S
Citation: A. Alousy et al., Structure and reactivity of low-spin iron(II)-diimine complexes: Effect ofligand nature and of solvent composition (DMSO-water) on base hydrolysis rate constants, IN REACT ME, 2(4), 2000, pp. 249-265
Authors:
Popov, I
Jelic, S
Radulovic, S
Radosavljevic, D
Nikolic-Tomasevic, Z
Citation: I. Popov et al., Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial, ANN ONCOL, 11(3), 2000, pp. 343-348
Authors:
Bosnjak, S
Radulovic, S
Neskovic-Konstantinovic, Z
Mitrovic, L
Citation: S. Bosnjak et al., Patient statement of satisfaction with antiemetic treatment is related to quality of life, AM J CL ONC, 23(6), 2000, pp. 575-578
Authors:
Yano, T
Radulovic, S
Osuga, Y
Kugu, K
Yoshikawa, H
Taketani, Y
Schally, AV
Citation: T. Yano et al., Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin analog RC-160, ONCOL-BASEL, 59, 2000, pp. 45-49
Authors:
Papp, J
Raicevic, L
Milasin, J
Dimitrijevic, B
Radulovic, S
Olah, E
Citation: J. Papp et al., Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families, ONCOL REP, 6(6), 1999, pp. 1435-1438
Authors:
Juranic, Z
Anastasova, F
Juranic, I
Stanojkovic, T
Radulovic, S
Vuletic, N
Citation: Z. Juranic et al., Antiproliferative action of isatine-beta-thiocarbohydrazone and N-ethylisatine-beta-thiocarbohydrazone on human PBMC and on two neoplastic cell lines, J EXP CL C, 18(3), 1999, pp. 317-324
Authors:
Radosevic-Jelic, L
Pekmezovic, T
Pavlovic-Cvetkovic, L
Radulovic, S
Petronic, V
Citation: L. Radosevic-jelic et al., Concomitant radiotherapy and carboplatin in locally advanced bladder cancer, EUR UROL, 36(5), 1999, pp. 401-405
Authors:
Susnjar, S
Vasovic, S
Neskovic-Konstantinovic, Z
Stamatovic, L
Lukic, V
Colakovic, S
Mitrovic, L
Jelic, S
Radulovic, S
Citation: S. Susnjar et al., Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study, TUMORI, 85(6), 1999, pp. 478-482
Authors:
Juranic, ZD
Stanojkovic, TP
Stanojevic-Bakic, N
Milosevic, D
Radulovic, S
Juranic, IO
Citation: Zd. Juranic et al., Lyophilized whole human melanoma cells stimulate human PBMC proliferation and enhance suppressive action of PBMC toward survival of the same malignant cell line in vitro, NEOPLASMA, 46(4), 1999, pp. 224-230
Authors:
Troyer, JM
Radulovic, S
Azad, AF
Citation: Jm. Troyer et al., Green fluorescent protein as a marker in Rickettsia typhi transformation, INFEC IMMUN, 67(7), 1999, pp. 3308-3311
Authors:
Radulovic, S
Troyer, JM
Beier, MS
Lau, AOT
Azad, AF
Citation: S. Radulovic et al., Identification and molecular analysis of the gene encoding Rickettsia typhi hemolysin, INFEC IMMUN, 67(11), 1999, pp. 6104-6108
Risultati:
1-13
|